Pharmaceutical firm celebrates milestone

Dublin People 21 Jun 2014
Minister of Transport, Tourism and Sport, Dr Leo Varadkar pictured with Ipsen’s Executive Vice President, Technical Operations, Jonathan Barnsley (right) and Dublin Site Vice President James Byrne (left).

LOCAL TD and Government minister, Leo Varadkar, was guest of honour at a celebration to mark the 25th anniversary of an innovative Dublin 15 based pharmaceutical group’s devel­- op­­ment in Ireland.

Ipsen Manufacturing Ireland established its plant in Ireland back in 1989, employing less than 10 staff, but has grown into a global specialty firm with around 100 employees.

The Blanchardstown based company is an Irish subsidiary of the Ipsen Group and a specialised centre for the bulk manufacture and development of a vital ingredient for two of Ipsen’s major products, Somatuline and Decapeptyl.

The company’s 25-year milestone was marked at a celebration attended by Ipsen stakeholders, staff and guests of honour including Minister Varadkar.

“Ipsen is an important employer in Dublin West with more than 100 staff, and it’s great to be here today to celebrate its 25th anniversary in Ireland,

? the minister said.

“In particular, biopharmaceutical companies like Ipsen provide important employment opportunities for highly qualified professionals in Dublin West.

Ipsen’s Executive Vice President, Technical Operations, Jonathan Barnsley added:

“We are delighted to celebrate the 25th anniversary of our state-of-the-art facility in Dublin with Dr Varadkar.

“His presence reflects his commitment to pharmaceutical companies and ultimately patients.

Ipsen’s Dublin Site Vice President James Byrne said:

“The greatest credit for our company’s success in Ireland must be given to our dedicated staff and tremendous pride taken in our Dublin plant.

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding e1.2 billion in 2013. The company’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases.

Related News